Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype

Details for Australian Patent Application No. 2001250221 (hide)

Owner Queen's University at Kingston

Inventors Heaton, Jeremy P. W; Graham, Charles H.; Postovit, Lynne-Marie; Adams, Michael A

Agent Spruson & Ferguson

Pub. Number AU-B-2001250221

PCT Pub. Number WO01/80890

Priority 60/277,469 21.03.01 US; 60/199,757 26.04.00 US

Filing date 26 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 6 July 2006

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/198 (2006.01)

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

6 July 2006 Application Accepted

  Published as AU-B-2001250221

23 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001250222

2001250220